These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7525695

  • 1. Asymptomatic anti-HCV seropositive subjects include patients with chronic active hepatitis and individuals with normal liver: can we distinguish them?
    Manzini P, Calvo PL, Abate ML, Cerchier A, Piantino P, Vallauri P, D'Antico S, Sympson B, Klarmann R, Schiffer M.
    J Hepatol; 1994 Jul; 21(1):136-7. PubMed ID: 7525695
    [No Abstract] [Full Text] [Related]

  • 2. Hepatitis C virus markers and de novo liver disease after transplantation: a prospective study.
    Franco A, Muñoz C, Jimenez L, Verdejo F, Arenas D, Olivares J.
    Transplant Proc; 1995 Aug; 27(4):2260-1. PubMed ID: 7544499
    [No Abstract] [Full Text] [Related]

  • 3. Liver biopsy is essential in anti-HCV (+) renal transplant patients irrespective of liver function tests and serology for HCV.
    Boletis J, Delladetsima J, Psimenou E, Vafiadi I, Tzala E, Katsoulidou A, Kostakis A, Hatzakis A, Vosnides G.
    Transplant Proc; 1995 Feb; 27(1):945-7. PubMed ID: 7533439
    [No Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus antibodies in dialysis pediatric patients.
    Di Loreto M, Ferrante M, Panaro A, Sorino P, Collela V, Caringella DA.
    Nephron; 1992 Feb; 61(3):365-6. PubMed ID: 1323793
    [Abstract] [Full Text] [Related]

  • 5. Comparison between first and second generation tests to determine the frequency of anti-HCV antibodies in uremic patients in replacement dialytic therapy.
    Mazzotta L, Landucci G, Pfanner L, Carlini A, Angelini D, Giusti R, Antonelli A.
    Nephron; 1992 Feb; 61(3):354-5. PubMed ID: 1323789
    [Abstract] [Full Text] [Related]

  • 6. Should the c100 antigen be removed from HCV antibody assays?
    Zaaijer HL, Cuypers HT, Reesink HW, Lelie PN.
    Vox Sang; 1994 Feb; 66(2):150. PubMed ID: 7514326
    [No Abstract] [Full Text] [Related]

  • 7. Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV.
    Lin HH, Hsu HY, Chang MH, Wang JT, Chen PJ, Chen DS.
    J Formos Med Assoc; 1992 Jul; 91(7):729-30. PubMed ID: 1360305
    [Abstract] [Full Text] [Related]

  • 8. A young woman with chronic hepatitis.
    Lok AS, Gerber MA.
    Hepatology; 1993 Apr; 17(4):739-45. PubMed ID: 7682983
    [No Abstract] [Full Text] [Related]

  • 9. Liver histology in anti-HCV-positive persons with normal or minimally elevated aminotransferases.
    Morales TG, Sampliner RE, Bhattacharyya A, Alter MJ.
    J Clin Gastroenterol; 1995 Dec; 21(4):301-5. PubMed ID: 8583105
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis C: diagnosis and treatment.
    Scotiniotis I, Brass CA, Malet PF.
    J Gen Intern Med; 1995 May; 10(5):273-82. PubMed ID: 7542329
    [No Abstract] [Full Text] [Related]

  • 11. Hepatitis C infection in BMT patients.
    Kolho E, Ruutu P, Ruutu T.
    Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
    [Abstract] [Full Text] [Related]

  • 12. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease.
    Roth D, Fernandez JA, Babischkin S, De Mattos A, Buck BE, Quan S, Olson L, Burke GW, Nery JR, Esquenazi V.
    Ann Intern Med; 1992 Sep 15; 117(6):470-5. PubMed ID: 1323944
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results.
    Baskin G, DiNello R, Polito A, Quan S, Lee WS, Wu J, Nelles M, Lee S.
    Gut; 1993 Sep 15; 34(2 Suppl):S61. PubMed ID: 7686119
    [Abstract] [Full Text] [Related]

  • 14. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up.
    Yousuf M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K.
    Scand J Gastroenterol; 1992 Sep 15; 27(9):812-6. PubMed ID: 1384112
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity.
    Mutimer DJ, Harrison RF, O'Donnell KB, Shaw J, Martin BA, Atrah H, Ala FA, Skidmore S, Hubscher SG, Neuberger JM.
    BMJ; 1994 Oct 01; 309(6958):847-8. PubMed ID: 7524875
    [No Abstract] [Full Text] [Related]

  • 16. Comparison between first- and second-generation test for anti-hepatitis C virus antibodies in hemodialysis patients.
    Da Porto A, Poli P, Calzavara P, Castelletto MR, Adami A, Cascone C, Amici GP, Teodori T, Okolicsanyi L.
    Nephron; 1992 Oct 01; 61(3):367-8. PubMed ID: 1323794
    [Abstract] [Full Text] [Related]

  • 17. Chronic non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction.
    Marcellin P, Martinot-Peignoux M, Gabriel F, Branger M, Degott C, Elias A, Xu LZ, Larzul D, Erlinger S, Benhamou JP.
    J Hepatol; 1993 Aug 01; 19(1):167-70. PubMed ID: 7507951
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improved detection of antibodies to hepatitis C virus by use of a new recombinant immunoblot assay.
    Joller-Jemelka HI, Wicki AN, Opitz R.
    Eur J Clin Microbiol Infect Dis; 1993 May 01; 12(5):398-400. PubMed ID: 7689054
    [No Abstract] [Full Text] [Related]

  • 20. Value of a new four-antigen recombinant immunoblot assay in predicting recurrence of hepatitis C virus infection following liver transplantation.
    Lumbreras C, Gimeno C, Colina F, Fuertes A, Lizasoain M, Aguado JM, Loinaz C, Iglesias J, Moreno E, Noriega AR.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 2):1463-5. PubMed ID: 7680162
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.